Because of an increasing development of antimicrobial resistance, treatment options for bacterial infectious diseases are narrowed. A strategy to reduce the evolution of resistance is to take advantage of antimicrobial collateral networks. In this thesis, we explored these collateral networks with a focus on antimicrobials used in Norway for the treatment of cystitis. Cystitis is the most common ...